Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,205 | 13,621 | 16,404 | 25,717 | 17,628 |
| Receivables | 2,622 | 2,897 | 2,961 | 3,926 | 1,463 |
| Inventories | 4,138 | 4,012 | 3,646 | 3,175 | 3,411 |
| Other current assets | 1,128 | 1,189 | 1,189 | 1,161 | 1,090 |
| TOTAL | $18,093 | $21,719 | $24,200 | $33,979 | $23,592 |
| Non-Current Assets | |||||
| PPE Net | 1,550 | 2,043 | 2,049 | 2,174 | 2,242 |
| Investments And Advances | 0 | 0 | 37 | 85 | 122 |
| Intangibles | 13,267 | 13,204 | 3,922 | 3,922 | 3,948 |
| Other Non-Current Assets | 2,312 | 2,798 | 3,158 | 3,090 | 2,106 |
| TOTAL | $17,129 | $18,045 | $9,166 | $9,271 | $8,418 |
| Total Assets | $35,222 | $39,764 | $33,366 | $43,250 | $32,010 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,965 | 790 | 9,800 | 9,784 | 9,767 |
| Accounts payable and accrued liabilities | 5,471 | 6,252 | 6,000 | 7,411 | 5,588 |
| Other current liabilities | 1,208 | 800 | 884 | 418 | N/A |
| TOTAL | $12,644 | $7,842 | $16,684 | $17,613 | $15,355 |
| Non-Current Liabilities | |||||
| Long Term Debt | 24,822 | 29,640 | 10,594 | 12,903 | 15,178 |
| Other Non-Current Liabilities | 0 | 0 | 2,500 | 2,250 | 4,271 |
| TOTAL | $25,766 | $30,659 | $14,314 | $19,182 | $26,387 |
| Total Liabilities | $38,410 | $38,501 | $30,998 | $36,795 | $41,742 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 67,270 | 67,236 | 67,183 | 67,173 | 58,832 |
| Common Shares | 67 | 67 | 67 | 66 | 59 |
| Retained earnings | -290,865 | -285,605 | -282,395 | -274,728 | -270,904 |
| Other shareholders' equity | -142 | -34 | -110 | 0 | 0 |
| TOTAL | $-3,188 | $1,263 | $2,368 | $6,455 | $-9,732 |
| Total Liabilities And Equity | $35,222 | $39,764 | $33,366 | $43,250 | $32,010 |